(Q28200486)

1

0 references

R A Agarwala

2

0 references

K D Dawkins

3

0 references

N P Curzen

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

4

0 references

language of work or name

English

0 references

publication date

September 2006

0 references

published in

Platelets

0 references

volume

17

0 references

issue

6

0 references

page(s)

385-92

0 references

cites work

1 reference

https://api.crossref.org/works/10.1080/09537100600757521

Stent thrombosis is associated with an impaired response to antiplatelet therapy

21 April 2017

1 reference

https://api.crossref.org/works/10.1080/09537100600757521

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 April 2017

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Platelet function testing in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Aspirin non-responder status in patients with recurrent cerebral ischemic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Platelet adhesion and aggregation in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

A Thrombelastograph whole blood assay for clinical monitoring of NSAID-insensitive transcellular platelet activation by arachidonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Comparison of modified Thrombelastograph and Plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Individual variations of platelet inhibition after loading doses of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09537100600757521